Last reviewed · How we verify
Evaluation of the Pharmacokinetics and Safety of Raltegravir and Ezetimibe When Co-administered to Male and Female Healthy Volunteers
Evaluation of the pharmacokinetics and safety of raltegravir and ezetimibe when co-administered to male and female healthy volunteers.
Details
| Lead sponsor | St Stephens Aids Trust |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 26 |
| Start date | 2008-06 |
| Completion | 2008-08 |
Conditions
- HIV
Interventions
- Raltegravir and ezetimibe
- Ezetimibe and raltegravir
Primary outcomes
- Steady state plasma concentrations of raltegravir and ezetimibe when given alone and in combination — 41 days
Countries
United Kingdom